Risk factors for treatment default in close contacts with latent tuberculous infection.
about
Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent InfectionManaging tuberculosis infection in children in the USA: an update.An evaluation of tuberculosis contact investigations against national standards.Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada.Prophylactic potential of defensins and L-isoleucine in tuberculosis household contacts: an experimental model.Knowledge about tuberculosis transmission and prevention and perceptions of health service utilization among index cases and contacts in Brazil: Understanding losses in the latent tuberculosis cascade of care.Genetic Clustering of Tuberculosis in an Indigenous Community of Brazil.Polymorphisms in Toll-Like Receptor 10 and Tuberculosis Susceptibility: Evidence from Three Independent Series.Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges.Completion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi.Predictors of latent tuberculosis infection treatment completion in the US private sector: an analysis of administrative claims data.Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support
P2860
Q35976624-6A7E708C-C5C9-4288-A1E5-156C14487ABEQ38831038-636189A4-A32A-4C90-BC02-164375721799Q38847143-E307DAE2-5085-496F-91C1-8A2E140486F6Q40764520-0FBFAF35-B75A-4FC9-80E5-5976A679B750Q41169862-81D80D4C-70F7-490B-B1FC-C464FE4235FBQ42362040-FAAEAC8B-5B8D-4311-B9C1-20B54EEE1ED6Q46310481-B3DF479E-8004-4AF9-B9F7-6708DF240420Q52661723-B24D96B8-206B-489A-A946-A1E24E5DE718Q52673482-D0FDD560-DF63-4877-9AF9-63E1F6F843F2Q54916195-A1869CD3-1673-4848-A827-3E5B805DDB6AQ55024668-2F90636A-D699-47C6-BCF3-3C71DE8B24DCQ58701366-B52D3253-3FAB-4AF8-9E55-0CAF361C456A
P2860
Risk factors for treatment default in close contacts with latent tuberculous infection.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Risk factors for treatment default in close contacts with latent tuberculous infection.
@ast
Risk factors for treatment default in close contacts with latent tuberculous infection.
@en
type
label
Risk factors for treatment default in close contacts with latent tuberculous infection.
@ast
Risk factors for treatment default in close contacts with latent tuberculous infection.
@en
prefLabel
Risk factors for treatment default in close contacts with latent tuberculous infection.
@ast
Risk factors for treatment default in close contacts with latent tuberculous infection.
@en
P2093
P2860
P356
P1476
Risk factors for treatment default in close contacts with latent tuberculous infection.
@en
P2093
M R Reichler
T R Sterling
Tuberculosis Epidemiologic Studies Consortium Task Order 2 Team
Y Hirsch-Moverman
P2860
P304
P356
10.5588/IJTLD.13.0688
P577
2014-04-01T00:00:00Z